baber/WOPTO huggingface dataset:
Patent NZ-562193-A (NZ)
Title: Sports audio player and two-way voice/data communication device
Inventor: FOTH ROBERT A
Filed: 2007-10-03
Abstract: Audio players and communications devices for use in sports, particularly aquatic sports such as bodyboarding, are disclosed. The device includes a housing (100) that encloses a flat panel audio transducer, and has a top panel acoustically coupled to the flat panel audio transducer. The housing is made of a material for conducting audio waves and is acoustically coupled to the top surface (51) of a body of material (50). In exemplary embodiments the body may be a bodyboard,a windsurfer board, a kayak, and the like. The device further includes a power source, electrical circuitry and an audio source connected to the flat panel audio transducer.
Patent NZ-569820-A (NZ)
Title: Carrier package with open ends and deformable top panel having a handle feature
Inventor: COLTRI-JOHNSON ANDREA
IPC: B65D71/00
Filed: 2007-01-11
Abstract: Disclosed is a carrier package with a deformable handle for a plurality of containers. The carrier has a bottom panel; a top panel (30); a first side panel (20); a second side panel; an at least partially open first end; an at least partially open second end; at least one handle feature (60) in the top panel; and a plurality of containers. The handle feature allows deformation of the top panel at at least one free end edge of the top panel.
Patent NZ-570921-A (NZ)
Title: Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
Inventor: FRIESS THOMAS
IPC: A61K39/395
Filed: 2007-03-20
Abstract: Disclosed is the use of an anti-HER2 antibody and an anti-VEGF antibody for the manufacture of a medicament for treating a breast cancer disease characterized by an overexpression of the HER2 receptor protein in a patient who has failed prior therapy with an anti-VEGF antibody, by simultaneous or separate administration to the patient of a therapeutically effective amount of an anti-HER2 antibody and an anti-VEGF antibody.
Patent NZ-580357-A (NZ)
Title: Chewable gelatinised protein dosage form and process
Inventor: SAUER BENJAMIN
IPC: A23K20/195
Filed: 2008-05-06
Abstract: A chewable, stable dosage form for animals comprising; a) about 20.0 - 70.0% w/w of gelatinised functional protein matrix, wherein the functional protein has an intact protein concentration i.e. minimal denaturation of the protein tertiary and quaternary structure, of greater than 65% w/w; b) about 0.001 - 40.000% w/w of one or more active ingredients; c) about 0.5 - 40.0% of one or more plasticisers which includes one or more oils and/or water; d) about 0.5 - 20.0% w/w of one or more humectants; e) optionally about 0.05 - 5.00% w/w of one or more anti-microbials; f) optionally about 0.05 - 5.00% w/w of one or more extrusion aids; g) optionally about 0.05 - 50.00% w/w of one or more flavouring agents; where c) - g) are incorporated in the gelatinised functional protein matrix and b) is incorporated in (i) the gelatinised protein matrix, (ii) a coating of the dosage form or (iii) both the gelatinised protein matrix and the coating. The dosage form has a total moisture content in the range of about 0.5 - 40.0% w/w and a water activity in the range of about 0.60 - 0.80 and less than about 0.1% w/w of gelatinised starch. The dosage form is prepared using a process that is carried out in the range of 30 - 70 degrees Celsius and at a pH of 5.0 - 7.5. These mild preparation conditions allow for the incorporation of the active ingredients without the loss of activity.
Patent NZ-589260-A (NZ)
Title: Handrail with light window and handgrips for an escalator or a moving walkway
Inventor: ILLEDITS THOMAS
IPC: B66B23/24
Filed: 2009-05-05
Abstract: Disclosed is a motor driven endless belt handrail for escalators or travelling walkways to improve safety through the use of lighting and grip elements. The oval or elliptical contoured handrail has a plurality of aligned grip elements that have an outer shell and internal lighting. The lighting is in an interior space bounded by the outer shell that has a transparent window region or strip positioned and/or connected laterally to the outer shell adjacent the lighting means. The grip region protrudes from the side of the handrail with a reduced oval or elliptical contour to that of the handrail. The window element is formed from acrylic glass or ABS or PMMA or Plexiglas or PET or Lucite or Makrolon or Lexan or polycarbonate. A solar element electrically connected with the lighting means is provided in the interior space of the outer shell. The lighting is electrically powered through the use of electrical contacts, conductor rail, and handrail guide profile member.
Patent NZ-590305-A (NZ)
Title: Authorisation server that allows access to restricted services and files based on a user's authorisation level
Inventor: DEAN IRVIN L
IPC: H04L9/32
Filed: 2009-05-13
Abstract: 590305 Disclosed is a secure portal system (10). The system (10) is comprised of at least one application server (16), a client computer (20) and a portal server (18). The application server (16) is operable to provide a plurality of secure services over a network. The client computer (20) is operable to display a graphical user interface (22). The portal server (18) couples the at least one application server (16) to the client computer (20). The portal server (18) is configured to create a login session with the graphical user interface (22), wherein the login session is associated with one authorisation level of a plurality of authorisation levels. The portal server (18) is also configured to display, on the graphical user interface (22), a service access point (24) for each of the plurality of secure services. The portal server (18) then restricts access to each of the plurality of secure services according to the one authorisation level of the login session. One of the plurality of secure services comprises a storage device that stores a plurality of files, each of the plurality of files having a tag indicating a file authorisation level of its respective file. The portal server (18) is configured to restrict access to the storage device by comparing the authorisation level of the login session with the file authorisation level of each of the plurality of files.
Patent NZ-597889-A (NZ)
Title: Manufacturing chamfer of panel thermoplastic face, typically flooring or ceiling, by heating, deforming and removal of material
Inventor: VAN VLASSENRODE KRISTOF
IPC: B29C35/08
Filed: 2012-01-30
Abstract: 597889 A method for manufacturing a chamfered edge with depth d along at least one edge of an upper surface of a plate shaped object, of which at least an upper layer comprises a thermoplastic (or similar) material, comprises the steps of heating the plate shaped object near to said edge; engaging the respective edge of said upper surface with pressure means for forming said chamfered edge by locally displacing material of the upper layer in a downward direction while displacing a substantially corresponding amount of material of the object in a substantially sideward direction outward of the original boundaries of the object; and removing the amount of material which has been displaced outward of the original boundaries of the object. Further a plate shaped object with an upper surface provided with a chamfered edge along at least one of the edges of said upper surface is provided.
Patent NZ-600997-A (NZ)
Title: Mitigation of alternate bearing
Inventor: LOVATT CAROL J
IPC: A01N43/08
Filed: 2010-12-28
Abstract: Discloses a method of mitigating alternate bearing in a perennial fruit tree, comprising administering to the perennial crop plant a composition comprising an effective amount of 9-beta-D-adenosine, adenosine, inosine, hypoxanthine and xanthine. Further discloses where the composition comprises 6-benzylaminopurine, zeatin, zeatinriboside, kinetin, isopentenyladenine, isopentenyladenosine, 1-(2-chloro-4-pyridynl)-3- phenylurea, gibberellic acid, 6-benzyladenine, 6-benzyladenosine, 2,3,5-triiodobenzoic acid, DPX 1840, 9-hydroxyflorene-9-carboxylic acid, and naptalam (N-1-naphthylphthalamic acid), fluridone (1-methyl-3-phenyl-5-[3-trifluromethyl(phenyl)]-4-(1H)-pyridinone), abamine, 1- butanol.
Patent NZ-601881-A (NZ)
Title: Phase identification system and method
Inventor: KULKARNI PRASAD
IPC: H02J13/00
Filed: 2012-08-16
Abstract: Disclosed is a phase identification system (70) for an electricity distribution network. The system (70) includes a power distribution station (12) having a phase distortion device (72). The phase distortion device (72) generates voltage distortions of a known harmonic frequency in at least one of three phase voltage signals of the power distribution station (12). The system also includes a phase detection device (22) configured to receive at least one of distorted three phase voltage signals and to identify a phase of the received voltage signal. The phase detection device (22) is comprised of a delay circuit, a transformation module and a phase determination module. The delay circuit generates a phase-shifted voltage signal of the received voltage signal. The transformation module transforms the received voltage signal and the phase-shifted voltage signal into d-q domain voltage signals of a known harmonic frequency reference frame. The phase determination module determines the phase of the received voltage signal by comparing an amplitude of a harmonic of the known harmonic frequency in the received voltage signal with a threshold value.
Patent NZ-604320-A (NZ)
Title: Suture delivery tools for endoscopic and robot-assisted surgery and methods
Inventor: AVELAR RUI
IPC: A61M25/01
Filed: 2011-06-10
Abstract: Disclosed is a suture delivery tool that releasably secures a self-retaining suture to permit delivery of the self-retaining suture to a surgical site in a patient through an access port. Suture delivery tools are disclosed suitable for manual operation and operation using robotically-assisted surgical systems. In some embodiments, a suture spool is part of a cartridge which is releasably attached to the suture delivery tool. Cartridges is, in some embodiments, replaced after deployment of the self-retaining suture and different cartridges having different self-retaining suture are, in some embodiments, selected and attached to the suture delivery tool as required for a procedure.
Patent NZ-621609-A (NZ)
Title: Method for providing transport units from a warehouse
Inventor: YAMASHITA SHIN
IPC: B65G1/137
Filed: 2013-07-17
Abstract: The invention relates to a logistics method for providing transport units or packages (T) from a warehouse (1) on at least one removal path, wherein the transport units (T) are moved in and out of the warehouse rack via one storing and removal device (5) per warehouse rack aisle (2). The method seeks to reduce the time taken palletising orders comprising boxes or other items by being able to move units (T) to adjacent racks or shelves (R) from their cross-conveying stations (Q) thereon for temporary or permanent storage.
Patent NZ-631238-A (NZ)
Title: Luggage apparatus
Inventor: CLARKE TAMAR
IPC: A47D1/02
Filed: 2013-03-28
Abstract: A baggage trolley or suitcase with an extendable section in the shape of a chair for a child or infant. The suitcase acts as a substitute pram or stroller when travelling. The suitcase (10) has a pivoting or hinged portion (14) that opens out to form the shape of a chair with cradles for the child’s legs and feet (14a, 14b) and includes a restraining bar or strap (70). It also includes multiple luggage compartments (16) and an extendable back panel that acts as the back of the chair (36). It optionally includes wheels and can be tilted or inclined such that it resembles a pram (40a, 40b, 40c).
Patent NZ-704192-A (NZ)
Title: Cell-penetrating peptides and uses therof
Inventor: HAAS ALEXANDER
IPC: C07K14/00
Filed: 2011-06-14
Abstract: Discloses a peptide attached to one or more nucleic acid molecules capable of being internalized into a cell, wherein the peptide molecule a) has a the sequence YLKVVRKHHRVIAGQFFGHHHTDSFRMLYD (SEQ ID NO: 4); which is internalized into a cell with an efficacy being at least 200% of the internalization efficacy of the TAT peptide having the amino acid sequence GRKKRRQRRRPPQ (SEQ ID NO: 1) and wherein the attachment is accomplished by a linkage selected from the group consisting of a covalent linkage and a non-covalent linkage.
Patent NZ-709502-A (NZ)
Title: New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
Inventor: FISCHER ANDREAS
IPC: A61P25/04
Filed: 2012-09-18
Abstract: Disclosed herein are tablets for sublingual administration comprising microparticles of buprenorphine or a pharmaceutically-acceptable salt thereof, particles of a weak acid, naloxone or a pharmaceutically-acceptable salt thereof and a disintegrant. The tablets are intended to provide a mode of abuse-resistant treatment for opioid dependence.
Patent NZ-718821-A (NZ)
Title: Anti-b7-h1 antibodies for treating tumors
Inventor: NARWAL RAJESH
IPC: C07K16/28
Filed: 2014-09-11
Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. A specific embodiment includes the use of the anti-B7-H1 (PD-L1) antibody MEDI4736 in the manufacture of a medicament for the treatment of a patient identified as having non-small cell lung carcinoma (NSCLC), wherein the antibody or antigen-binding fragment thereof specifically binds to PD-L1, wherein at least 25% of the NSCLC tumour cells are PD-L1 positive, and wherein the treatment comprises administration of about 10 mg/kg or about 15 mg/kg of the antibody or antigen-binding fragment thereof to the patient.
Patent NZ-723645-A (NZ)
Title: Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
Inventor: FORD JOHN
IPC: A61P9/00
Filed: 2014-02-05
Abstract: The present invention relates to a cholesteryl ester transfer protein (CETP) inhibitor of compound A at a dosage of 1 to 25 mg per day for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, in particular hyperlipidemia or mixed dyslipidemia. A further aspect of the present invention relates to a pharmaceutical composition for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, wherein the composition comprises a therapeutically effective amount of said CETP inhibitor.
Patent NZ-724014-A (NZ)
Title: Humanized m-csf mice
Inventor: MURPHY ANDREW J
IPC: A01K67/027
Filed: 2012-02-14
Abstract: Disclosed is a humanized M-CSF mouse, comprising a nucleic acid sequence incorporated into the genome of the humanized M-CSF mouse, which sequence encodes a human M-CSF protein and is operably linked to a regulatory sequence 5’ of the mouse M-CSF structural gene locus; wherein the mouse is immunocompromised for a mouse immune system as a result of one or more of the following: sub-lethal irradiation, the mouse is a NOD-SCID mouse, the mouse is a NOD-scid γc−/− (NSG) mouse, and the mouse is a NOD/Shi-scid γc−/− (NOG) mouse; and wherein the mouse expresses M-CSF RNA encoded by the nucleic acid sequence in bone marrow, spleen, blood, liver, brain, lung, testis and kidney Further disclosed is a method for making an activated human monocyte and/or activated human macrophage, comprising exposing a humanized M-CSF mouse to an immune stimulant under conditions sufficient for human monocytes and/or macrophages in the mouse to become activated, and isolating human monocytes and/or human macrophages from the mouse, wherein the mouse comprises a nucleic acid sequence incorporated into the genome of the mouse, which sequence encodes a human M-CSF protein and is operably linked to the endogenous promoter of the mouse M-CSF gene at the mouse M-CSF locus, wherein the mouse is immunocompromised for a mouse immune system, wherein the mouse comprises human hematopoietic cells, and wherein the mouse expresses M-CSF RNA encoded by the nucleic acid sequence in bone marrow, spleen, blood, liver, brain, lung, testis and kidney. Further disclosed is a method of isolating biologically active human M-CSF, the method comprising isolating biologically active human MCSF from a humanized M-CSF mouse, wherein the mouse comprises a nucleic acid sequence incorporated into the genome of the mouse, which sequence encodes a human M-CSF protein and is operably linked to the endogenous promoter of the mouse M-CSF gene at the mouse M-CSF locus, wherein the mouse is immunocompromised for a mouse immune system, and wherein the mouse expresses M-CSF RNA encoded by the nucleic acid sequence in bone marrow, spleen, blood, liver, brain, lung, testis and kidney.
Patent NZ-731095-A (NZ)
Title: Compositions and methods for treating cns disorders
Inventor: SALITURO FRANCESCO
IPC: A01N51/00
Filed: 2015-10-16
Abstract: Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein, R1, R2a, R2b, R3and A are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.
Patent NZ-731669-A (NZ)
Title: Phospholipid ether analogs as cancer-targeting drug vehicles
Inventor: WEICHERT JAMEY
IPC: A61K31/395
Filed: 2015-11-06
Abstract: The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds. A therapeutic compound comprising the formula A-B-D wherein: A is at least one compound of formula (I).
Patent NZ-738712-A (NZ)
Title: Removable lingual-vestibular dental alignment device and method for the production thereof
Inventor: JIMÉNEZ CARABALLO SANTIAGO
IPC: A61C7/00
Filed: 2013-01-02
Abstract: The invention relates to a removable lingual-vestibular dental alignment device comprising an assembly of independent caps (12), and to a method for producing the caps (12). The method includes scanning the mould of the denture and working on a virtual mould in order to include the corrective elements. The caps (12, 35) are produced after printing the result of the denture (9) with the different elements and subsequent stamping method or from the printing of a file corresponding to a virtual cap produced on the virtual denture (8) that includes the virtual cuboids (4) and virtual half-spheres (5). The invention provides a method for visualizing the alignment of the device and the corresponding distribution of forces in the patient’s mouth before the device is fitted, which is in contrast to conventional methods where the choice and placement of braces is done by the doctor based only on their experience.
Patent NZ-762120-A (NZ)
Title: Apparatus and method for a remediation plant
Inventor: FELTMAN WENDELL
IPC: B01D3/38
Filed: 2019-02-06
Abstract: A method for recovering drilling fluid from drilling mud and cuttings, by using a remediation plant which comprises a vacuum distillation unit (VDU), a condenser and an oil water separator. The mud is distilled in the VDU and the temperature adjusted so that only hydrocarbons with a chain length up to C24 are vapourised. The vapour is then condensed in the condenser, and the oil/water separator used to obtain the recovered fluid. The vacuum distillation unit allows the use of lower temperatures for distillation and so prevents cracking of the recovered fluid
Patent NZ-769536-A (NZ)
Title: Safety iv catheter with v-clip interlock and needle tip capture
Inventor: STOKES JOHN
IPC: A61M5/32
Filed: 2015-11-09
Abstract: A catheter assembly comprises a catheter, a needle having a sharp distal tip disposed in the catheter, a catheter hub housing the catheter and the needle, the catheter hub having a collar including a notch, a needle shield connected to the catheter hub when the needle is in a first position, and a clip (710) disposed in the needle shield that cooperates with the needle. The clip engages the catheter hub in the first position of the needle and disengages the catheter hub when the needle is retracted to a second position to cover at least a portion of the needle. The needle shield including a mounting protrusion. The clip includes a mounting cavity (738) configured to engage the mounting protrusion to secure the clip to the needle shield and avoid undesired movement or tampering of the clip.
Patent OA-11913-A (OA)
Title: Assaying.
Inventor: BRITS WILLEM HENDRIK
IPC: G01N33/20
Filed: 1999-10-29
Abstract: This invention relates to a method for assaying an ore sample to determine the concentration of gold and PGMs therein. The method comprises the steps of preparing an ore sample, combining the prepared ore sample with a lead-containing flux, inductively heating the combination (typically at a predetermined reference temperature profile) to form a fusion of slag and lead containing the gold and PGM's in the sample and separating the lead from the slag. The invention also covers a new flux for the process, the flux containing sodium hydroxide, a container for mixing the flux and an ore sample and an apparatus for separating molten lead from slag.
Patent PT-101817-A (PT)
Title: System for converting the kinetic energy of sea waves into electrical energy
IPC: E02B9/08
Filed: 1996-01-25
Abstract: The invention relates to a hydro-mechanical system that converts the propulsive force of waves into the potential energy of a body and the potential energy of this body into electrical energy. According to the invention, the body is a float 3 threaded on a column 2 fixed to a block 7 of concrete resting on the sea-bottom. The float 3 is mechanically connected to a telescopic hydraulic cylinder 4 which is situated inside the column 2. When the float 3 rises, by wave action, the cylinder 4 fills with sea- water via the filter 5 and the non-return valve 6. When the wave passes the float 3, it exerts all its weight on the water contained inside the cylinder 4, forcing it to exit and be thrown against the blades of a turbine. The turbine is coupled to an AC generator that converts the mechanical energy into electrical energy, and they are installed in the station 1. In order for the turbine to operate continuously, a second assembly is installed, at a specified distance, connected to the first. The invention is used in the generation of electrical energy from a renewable and non-polluting energy source. <IMAGE>
Patent PT-104984-A (PT)
Title: Mesa multimédia interactiva multi-toque
Inventor: CARVALHO RUI FILIPE RIBEIRO PICAS DE
IPC: G06F3/042
Filed: 2010-02-26
Abstract: O PRESENTE INVENTO DIZ RESPEITO A UMA MESA MULTIMÉDIA INTERACTIVA MULTI-TOQUE COM SISTEMA E MÉTODO DE PROJECÇÃO E INTERACÇÃO COM CONTEÚDOS MULTIMÉDIA CAPAZ DE INTERAGIR COM DIVERSOS UTILIZADORES SIMULTANEA¬MENTE. É ESSENCIALMENTE CARACTERIZADA POR COMPREENDER UMA ESTRUTURA FÍSICA MÓVEL ENVOLVENTE [A] NO QUAL É INSERIDO UM SISTEMA DE PROJECÇÃO DIRECTA [1] CAPAZ DE PROJECTAR CONTEÚDOS COM ALTA RESOLUÇÃO ORIGINÁRIOS DE UMA UNIDADE DE PROCESSAMENTO [3] OU OUTRO QUALQUER SISTEMA EXTERNO; UM SISTEMA DE AQUISIÇÃO DE IMAGEM [2] QUE CONJUGADO COM A UNIDADE DE PROCESSAMENTO [3] DETECTA E IDENTIFICA AUTOMATICAMENTE, SEM QUALQUER LIMITAÇÃO, TODAS AS ACÇÕES DOS UTILIZADORES SOBRE A MESA BEM COMO OBJECTOS FÍSICOS COM MARCAS; UM SISTEMA DE SOM; E UM TAMPO [4] QUE É CONSTITUÍDO POR UM SISTEMA DE EMISSÃO DE INFRA-VERMELHOS, POR UMA SUPERFÍCIE SEMI-TRANSPARENTE RESISTENTE ÀS INVESTIDAS DOS UTILIZADORES, POR UMA PELÍCULA DE FIXAÇÃO DE IMAGEM E UMA PELÍCULA ANTIADERENTE.